Oral Presentation of The First Phase I Clinical Trial of AT278 at ATTD

Oral Presentation: AT278 (U500) – PK/PD and safety of rapid-acting concentrated insulin aspart

Presenting Author: Dr Eva Svehlikova

Session: Oral Presentations Session 2

Date and Time: Thursday, 28 April 2022, at 17:20 Central European Time